Mastocytosis, Systemic - 25 Studies Found
Recruiting |
: Evaluation of Response of Dasatinib to Treat Mastocytosis : Systemic Mastocytosis : 2009-09-16 : Drug: Dasatinib Starting dosage 20mg once daily, that can be escalated up to 100mg once daily. Patient w |
Recruiting |
: A Study to Evaluate the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of AK002 : Indolent Systemic Mastocytosis : 2016-06-16 : Drug: AK002 |
Recruiting |
: Brentuximab Vedotin in Treating Patients With Advanced Systemic Mastocytosis or Mast Cell Leukemia :
: Drug: brentuximab vedotin Brentuximab vedotin is an antibody with a covalently attached toxin. The antib |
Completed |
: Patient-Reported Outcome Questionnaire for Systemic Mastocytosis :
|
Recruiting |
: Study of BLU-285 in Patients With Advanced Systemic Mastocytosis (advSM) and Relapsed or Refractory Myeloid Malignancies :
|
Active, not recruiting |
: Phase II Midostaurin in Aggressive Systemic Mastocytosis and Mast Cell Leukemia :
: Drug: Midostaurin Midostaurin is a broad-spectrum protein kinase inhibitor, acting on conventional PKC i |
Completed |
: Stem Cell Transplantation to Treat Systemic Mastocytosis : Mastocytosis : 2000-10-17 : Procedure: Stem cell transplantation |
Recruiting |
: SL-401 in Advanced, High Risk Myeloproliferative Neoplasms (Systemic Mastocytosis, Advanced Symptomatic Hypereosinoophic Disorder, Myelofibrosis, Chronic Myelomonocytic Leukemia) :
|
Recruiting |
: Study of Mast Cell Precursors :
: 1999-11-03 |
Completed |
: Cytokine Production Patterns in Patients With Systemic Mastocytosis Compared With Atopic Dermatitis and Healthy Individuals :
: 1999-11-03 |